BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Campbell M, Williams MT. The Ethic of Access: An AIDS Activist Won Public Access to Experimental Therapies, and This Must Now Extend to Psychedelics for Mental Illness. Front Psychiatry 2021;12:680626. [PMID: 34290631 DOI: 10.3389/fpsyt.2021.680626] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Smith WR, Appelbaum PS. Novel ethical and policy issues in psychiatric uses of psychedelic substances. Neuropharmacology 2022;:109165. [PMID: 35718006 DOI: 10.1016/j.neuropharm.2022.109165] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Argento E, Christie D, Mackay L, Callon C, Walsh Z. Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems. Front Psychiatry 2021;12:716593. [PMID: 34552518 DOI: 10.3389/fpsyt.2021.716593] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]